A Registry Study for Pediatric Patients With Antiphospholipid Syndrome (the immune system wrongly attacks normal blood proteins)

This research study will take a look at Antiphospholipid Syndrome in order to learn how to better diagnose and control it.

a study on Antiphospholipid Syndrome

Summary

Eligibility
for people ages up to 18 years (full criteria)
Location
at UC Davis
Dates
study started
completion around
Principal Investigator
by Lavjay Butani, M.D. (ucdavis)

Description

Summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Official Title

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Keywords

Antiphospholipid Syndrome, Syndrome

Eligibility

You can join if…

Open to people ages up to 18 years

  • 18 years of age or younger at the onset of disease
  • Presence of Vascular Thrombosis
  • UC Davis patient
  • Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

You CAN'T join if...

  • Infants born to mothers with APS
  • Infants with congenital thrombophilia

Location

  • UC Davis Medical Center accepting new patients
    Sacramento California 95817 United States

Lead Scientist at University of California Health

  • Lavjay Butani, M.D. (ucdavis)
    Professor, Pediatrics, School of Medicine. Authored (or co-authored) 131 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
Links
Learn more or sign up for the study here!
ID
NCT00616317
Study Type
Observational
Participants
Expecting 50 study participants
Last Updated